- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10
- 11
- 12
- 13
- 14
- 15
- 16
- 17
- 18
- 19
- 20
- 21
- 22
- 23
- 24
- 25
- 26
- 27
- 28
- 29
- 30
- 31
- 32
- 33
- 34
- 35
- 36
- 37
- 38
- 39
- 40
VRIO Analysis of Valeant Pharmaceuticals International Inc Case A Incentive Compensation Acquisitions and Financial Performance
Posted by Zachary Edwards on Mar-22-2018
The VRIO Analysis of Valeant Pharmaceuticals International Inc Case A Incentive Compensation Acquisitions and Financial Performance will look at each of its internal resources one by one to assess whether these provide sustained competitive advantage. The Valeant Pharmaceuticals International Inc Case A Incentive Compensation Acquisitions and Financial Performance VRIO Analysis also mentions at each stage whether these resources could be improved to provide a greater competitive advantage. Lastly, the resources analysed are summarised as to whether they offer sustained competitive advantage, has an unused competitive advantage, temporary competitive advantage, competitive parity or competitive disadvantage.
Valuable
- The Valeant Pharmaceuticals International Inc Case A Incentive Compensation Acquisitions and Financial Performance VRIO Analysis shows that the financial resources of Valeant Pharmaceuticals International Inc Case A Incentive Compensation Acquisitions and Financial Performance are highly valuable as these help in investing into external opportunities that arise. These also help Valeant Pharmaceuticals International Inc Case A Incentive Compensation Acquisitions and Financial Performance in combating external threats.
- According to the VRIO Analysis of Valeant Pharmaceuticals International Inc Case A Incentive Compensation Acquisitions and Financial Performance, its local food products are a valuable resource as these are highly differentiated. This makes the perceived value for these by customers high. These are also valued more than the competition by customers due to the differentiation in these products.
- The Valeant Pharmaceuticals International Inc Case A Incentive Compensation Acquisitions and Financial Performance VRIO Analysis shows that Valeant Pharmaceuticals International Inc Case A Incentive Compensation Acquisitions and Financial Performance's employees are a valuable resource to the firm. A significant portion of the workforce is highly trained, and this leads to more productive output for the organisation. The employees are also loyal, and retention levels for the organisation are high. All of this translates into greater value for the end consumers of Valeant Pharmaceuticals International Inc Case A Incentive Compensation Acquisitions and Financial Performance's products.
- According to the VRIO Analysis of Valeant Pharmaceuticals International Inc Case A Incentive Compensation Acquisitions and Financial Performance, its patents are a valuable resource as these allow the firm to sell its products without competitive interference. This results in greater revenue for Valeant Pharmaceuticals International Inc Case A Incentive Compensation Acquisitions and Financial Performance. These patents also provide Valeant Pharmaceuticals International Inc Case A Incentive Compensation Acquisitions and Financial Performance with licensing revenue when it licenses these patents out to other manufacturers.
- The Valeant Pharmaceuticals International Inc Case A Incentive Compensation Acquisitions and Financial Performance VRIO Analysis shows that Valeant Pharmaceuticals International Inc Case A Incentive Compensation Acquisitions and Financial Performance’s distribution network is a valuable resource. This helps it in reaching out to more and more customers. This ensures greater revenues for Valeant Pharmaceuticals International Inc Case A Incentive Compensation Acquisitions and Financial Performance. It also ensures that promotion activities translate into sales as the products are easily available.
- According to the VRIO Analysis of Valeant Pharmaceuticals International Inc Case A Incentive Compensation Acquisitions and Financial Performance, its cost structure is not a valuable resource. This is because the methods of production lead to greater costs than that of competition, which affects the overall profits of the firm. Therefore, its cost structure is a competitive disadvantage that needs to be worked on.
- The Valeant Pharmaceuticals International Inc Case A Incentive Compensation Acquisitions and Financial Performance VRIO Analysis shows that the research and development at Valeant Pharmaceuticals International Inc Case A Incentive Compensation Acquisitions and Financial Performance is not a valuable resource. This is because research and development are costing more than the benefits it provides in the form of innovation. There have been very few innovative features and breakthrough products in the past few years. Therefore, research and development are a competitive disadvantage for Valeant Pharmaceuticals International Inc Case A Incentive Compensation Acquisitions and Financial Performance. It is recommended that the research and development teams are improved, and costs are cut for these.
Rare
- The financial resources of Valeant Pharmaceuticals International Inc Case A Incentive Compensation Acquisitions and Financial Performance are found to be rare according to the VRIO Analysis of Valeant Pharmaceuticals International Inc Case A Incentive Compensation Acquisitions and Financial Performance. Strong financial resources are only possessed by a few companies in the industry.
- The local food products are found to be not rare as identified by Valeant Pharmaceuticals International Inc Case A Incentive Compensation Acquisitions and Financial Performance VRIO Analysis. These are easily provided in the market by other competitors. This means that competitors can use these resources in the same way as Valeant Pharmaceuticals International Inc Case A Incentive Compensation Acquisitions and Financial Performance and inhibit competitive advantage. This means that the local food products result in competitive parity for Valeant Pharmaceuticals International Inc Case A Incentive Compensation Acquisitions and Financial Performance. As this resource is valuable, Valeant Pharmaceuticals International Inc Case A Incentive Compensation Acquisitions and Financial Performance can still make use of this resource.
- The employees of Valeant Pharmaceuticals International Inc Case A Incentive Compensation Acquisitions and Financial Performance are a rare resource as identified by the VRIO Analysis of Valeant Pharmaceuticals International Inc Case A Incentive Compensation Acquisitions and Financial Performance. These employees are highly trained and skilled, which is not the case with employees in other firms. The better compensation and work environment ensure that these employees do not leave for other firms.
- The patents of Valeant Pharmaceuticals International Inc Case A Incentive Compensation Acquisitions and Financial Performance are a rare resource as identified by the Valeant Pharmaceuticals International Inc Case A Incentive Compensation Acquisitions and Financial Performance VRIO Analysis. These patents are not easily available and are not possessed by competitors. This allows Valeant Pharmaceuticals International Inc Case A Incentive Compensation Acquisitions and Financial Performance to use them without interference from the competition.
- The distribution network of Valeant Pharmaceuticals International Inc Case A Incentive Compensation Acquisitions and Financial Performance is a rare resource as identified by the VRIO Analysis of Valeant Pharmaceuticals International Inc Case A Incentive Compensation Acquisitions and Financial Performance. This is because competitors would require a lot of investment and time to come up with a better distribution network than that of Valeant Pharmaceuticals International Inc Case A Incentive Compensation Acquisitions and Financial Performance. These are also possessed by very few firms in the industry.
Imitable
- The financial resources of Valeant Pharmaceuticals International Inc Case A Incentive Compensation Acquisitions and Financial Performance are costly to imitate as identified by the Valeant Pharmaceuticals International Inc Case A Incentive Compensation Acquisitions and Financial Performance VRIO Analysis. These resources have been acquired by the company through prolonged profits over the years. New entrants and competitors would require similar profits for a long period of time to accumulate these amounts of financial resources.
- The local food products are not that costly to imitate as identified by the VRIO Analysis of Valeant Pharmaceuticals International Inc Case A Incentive Compensation Acquisitions and Financial Performance. These can be acquired by competitors as well if they invest a significant amount in research and development. These also do not require years long experience. Therefore, the local food products by Valeant Pharmaceuticals International Inc Case A Incentive Compensation Acquisitions and Financial Performance provide it with a temporary competitive advantage that competitors can too acquire in the long run.
- The employees of Valeant Pharmaceuticals International Inc Case A Incentive Compensation Acquisitions and Financial Performance are also not costly to imitate as identified by the Valeant Pharmaceuticals International Inc Case A Incentive Compensation Acquisitions and Financial Performance VRIO Analysis. This is because other firms can also train their employees to improve their skills. These companies can also hire employees from Valeant Pharmaceuticals International Inc Case A Incentive Compensation Acquisitions and Financial Performance by offering better compensation packages, work environment, benefits, growth opportunities etc. This makes the employees of Valeant Pharmaceuticals International Inc Case A Incentive Compensation Acquisitions and Financial Performance a resource that provides a temporary competitive advantage. Competition can acquire these in the future.
- The patents of Valeant Pharmaceuticals International Inc Case A Incentive Compensation Acquisitions and Financial Performance are very difficult to imitate as identified by the VRIO Analysis of Valeant Pharmaceuticals International Inc Case A Incentive Compensation Acquisitions and Financial Performance. This is because it is not legally allowed to imitate a patented product. Similar resources to be developed and getting a patent for them is also a costly process.
- The distribution network of Valeant Pharmaceuticals International Inc Case A Incentive Compensation Acquisitions and Financial Performance is also very costly to imitate by competition as identified by the Valeant Pharmaceuticals International Inc Case A Incentive Compensation Acquisitions and Financial Performance VRIO Analysis. This has been developed over the years gradually by Valeant Pharmaceuticals International Inc Case A Incentive Compensation Acquisitions and Financial Performance. Competitors would have to invest a significant amount if they are to imitate a similar distribution system.
Organisation
- The financial resources of Valeant Pharmaceuticals International Inc Case A Incentive Compensation Acquisitions and Financial Performance are organised to capture value as identified by the VRIO Analysis of Valeant Pharmaceuticals International Inc Case A Incentive Compensation Acquisitions and Financial Performance. These resources are used strategically to invest in the right places; making use of opportunities and combatting threats. Therefore, these resources prove to be a source of sustained competitive advantage for Valeant Pharmaceuticals International Inc Case A Incentive Compensation Acquisitions and Financial Performance.
- The Patents of Valeant Pharmaceuticals International Inc Case A Incentive Compensation Acquisitions and Financial Performance are not well organised as identified by the Valeant Pharmaceuticals International Inc Case A Incentive Compensation Acquisitions and Financial Performance VRIO Analysis. This means that the organisation is not using these patents to their full potential. An unused competitive advantage exists that can be changed into a sustainable competitive advantage if Valeant Pharmaceuticals International Inc Case A Incentive Compensation Acquisitions and Financial Performance starts selling patented products before the patents expire.
- The distribution network of Valeant Pharmaceuticals International Inc Case A Incentive Compensation Acquisitions and Financial Performance is organised as identified by the VRIO Analysis of Valeant Pharmaceuticals International Inc Case A Incentive Compensation Acquisitions and Financial Performance. Valeant Pharmaceuticals International Inc Case A Incentive Compensation Acquisitions and Financial Performance uses this network to reach out to its customers by ensuring that products are available on all of its outlets. Therefore, these resources prove to be a source of sustained competitive advantage for Valeant Pharmaceuticals International Inc Case A Incentive Compensation Acquisitions and Financial Performance.
From the VRIO Analysis of Valeant Pharmaceuticals International Inc Case A Incentive Compensation Acquisitions and Financial Performance, it was identified that the financial resources and distribution network provide a sustained competitive advantage. The patents are a source of unused competitive advantage. There exists a temporary competitive advantage for employees. There exists a competitive parity for local food products. Lastly, the cost structure of Valeant Pharmaceuticals International Inc Case A Incentive Compensation Acquisitions and Financial Performance is a competitive disadvantage. Research and Development is also a competitive disadvantage.
Warning! This article is only an example and cannot be used for research or reference purposes. If you need help with something similar, please submit your details here.
Sumarno Vishal
5.0
The point that I liked most in the article was that the writer didn’t repeat any word. Feeling blessed to have a writer like you!
Alexey Shapoval
5.0
The supervisor didn't bother me for correction owing to the paper being composed by the skilled expert.
Lucy Chua
5.0
The expert fully concentrated on the most demanded subject means Economics. Thank you so much!
Vivian Yu
5.0
There should be no star limit for this service that is very wholehearted and genuine to its work. Will surely suggest it to friends.
Next Articles
- The Future Of Growth: AI Comes Of Age Vrio Analysis
- The Failure Of Westinghouse Vrio Analysis
- Deals On Wheels Inc., Horizontal And Vertical Analysis Assignment Hints Vrio Analysis
- Clover (B): What Was Dean Nelson Thinking? KKR's Viewpoint Vrio Analysis
- Creating Great Choices: A Leader's Guide To Integrative Thinking Vrio Analysis
- The National Women's Soccer League: Towards The Successful Professionalization Of Women's Soccer? Vrio Analysis
- Holson Forest Products Ltd.: The Challenge Of International Markets Vrio Analysis
- A Winning Formula: Disruptive Innovation + Jobs To Be Done Vrio Analysis
- France's "Horsegate" Scandal: Marketing Communications Addressing The Aftermath Of A Food Fraud/Product Recall Vrio Analysis
- Valeant Pharmaceuticals International, Inc.: Case (B) Corporate Crisis In 2015 And 2016 Vrio Analysis
Previous Articles
- VivaColombia: The Challenge Of Growing A Low Cost Airline In Latin America Vrio Analysis
- Deals On Wheels Inc. Vrio Analysis
- The New Leadership Imperative: Embracing Digital Transformation Vrio Analysis
- Moonshots: Achieving Breakthrough Innovation In Established Organizations Vrio Analysis
- TelePizza (Abridged) Vrio Analysis
- James McAllister: Learning From BP And NASA Vrio Analysis
- Reputation Management Goes Digital Vrio Analysis
- How To Sense And Seize Opportunities And Transform Your Organization Vrio Analysis
- CEO Spotlight: Staying Relevant In An Age Of Transformation Vrio Analysis
- Recruiting: Additional Vignettes Vrio Analysis
Be a great writer or hire a greater one!
Academic writing has no room for errors and mistakes. If you have BIG dreams to score BIG, think out of the box and hire Case48 with BIG enough reputation.
Our Guarantees
Interesting Fact
Most recent surveys suggest that around 76 % students try professional academic writing services at least once in their lifetime!